RNXT
RenovoRx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.69
−2.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 45.95x
- P/S forward
- 11.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.49x
- Price / sales
- 38.60x
- Price / cash flow
- -6.43x
Enterprise value
- Enterprise value
- $67.0M
- EV / sales
- 33.93x
- EV / EBITDA
- -5.46x
- EV / EBIT
- -5.00x
- Market cap
- $76.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026